Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Bighelli

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The Cochrane Database of Systematic Reviews|August 30, 2022
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophreniaIrene Bighelli, Alessandro Rodolico, Spyridon Siafis, et al.
The Lancet. Psychiatry|July 20, 2019
Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysisJohannes Schneider-Thoma, Orestis Efthimiou, Irene Bighelli, et al.
The Cochrane Database of Systematic Reviews|October 1, 2014
Azapirones versus placebo for panic disorder in adultsHissei Imai, Aran Tajika, Peiyao Chen, et al.
BMC Psychiatry|December 6, 2018
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysisIrene Bighelli, Maximilian Huhn, Johannes Schneider-Thoma, et al.
International Journal of Mental Health Systems|May 4, 2013
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcareGiovanni Ostuzzi, Irene Bighelli, Barbara-Vanessa Carrara, et al.
Eclinicalmedicine|June 3, 2026
Next-step treatment for schizophrenia non-responsive to antipsychotics: a systematic review and network meta-analysisYuki Furukawa, Nurul Husna Salahuddin, Yaohui Wei, et al.
Therapeutic Advances in Psychopharmacology|December 5, 2017
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive natureAndreas D Meid, Irene Bighelli, Sarah Mächler, et al.
Nature Reviews. Disease Primers|November 27, 2025
SchizophreniaStefan Leucht, Spyridon Siafis, John J McGrath, et al.
Human Psychopharmacology|June 2, 2016
First-generation antipsychotics and QTc: any role for mediating variables?Giuseppe Carrà, Cristina Crocamo, Francesco Bartoli, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 8, 2018
Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysisIrene Bighelli, Georgia Salanti, Maximilian Huhn, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The Cochrane Database of Systematic Reviews|August 30, 2022
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophreniaIrene Bighelli, Alessandro Rodolico, Spyridon Siafis, et al.
The Lancet. Psychiatry|July 20, 2019
Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysisJohannes Schneider-Thoma, Orestis Efthimiou, Irene Bighelli, et al.
The Cochrane Database of Systematic Reviews|October 1, 2014
Azapirones versus placebo for panic disorder in adultsHissei Imai, Aran Tajika, Peiyao Chen, et al.
BMC Psychiatry|December 6, 2018
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysisIrene Bighelli, Maximilian Huhn, Johannes Schneider-Thoma, et al.
International Journal of Mental Health Systems|May 4, 2013
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcareGiovanni Ostuzzi, Irene Bighelli, Barbara-Vanessa Carrara, et al.
Eclinicalmedicine|June 3, 2026
Next-step treatment for schizophrenia non-responsive to antipsychotics: a systematic review and network meta-analysisYuki Furukawa, Nurul Husna Salahuddin, Yaohui Wei, et al.
Therapeutic Advances in Psychopharmacology|December 5, 2017
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive natureAndreas D Meid, Irene Bighelli, Sarah Mächler, et al.
Nature Reviews. Disease Primers|November 27, 2025
SchizophreniaStefan Leucht, Spyridon Siafis, John J McGrath, et al.
Human Psychopharmacology|June 2, 2016
First-generation antipsychotics and QTc: any role for mediating variables?Giuseppe Carrà, Cristina Crocamo, Francesco Bartoli, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 8, 2018
Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysisIrene Bighelli, Georgia Salanti, Maximilian Huhn, et al.
Pageof 9